Of course! The CA-15.3 test, often called “oncomammography,” is a blood test that gauges the concentration of the protein CA-15.3, a tumor marker mostly linked to breast cancer. The main uses of CA-15.3 are to track the course of treatment for female breast cancer patients and to look for recurrence after treatment. Due to its low sensitivity and specificity, this marker is not usually utilized for initial diagnosis; however, it might give important information on how the disease progresses or recedes during and after therapy.
The inclusion of “health heart diagnostics” healthesh in the CA-15.3 test description draws attention to the wider effects of cancer treatment on cardiovascular health. Chemotherapy and hormone treatments for breast cancer can have serious adverse effects on the circulatory system that can affect heart function. In light of this, monitoring CA-15.3 levels